![Frédéric Dumais](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frédéric Dumais
Investor Relations Contact at
VALEO PHARMA INC.
Profile
Frédéric Dumais is currently the Director of Communications & Investor Relations at ChitogenX, Inc., Director of Communications & Investor Relations at Valeo Pharma, Inc., and a Member of the Québec Bar Association.
In the past, he held positions as Director of Communications & Investor Relations at Liminal BioSciences, Inc., Vice President of Investor Relations at LAB International, Inc. and Akela Pharma, Inc., and Head of Investor Relations at Janssen Pharmaceutica NV.
Frédéric Dumais active positions
| Companies | Position | Start |
|---|---|---|
| VALEO PHARMA INC. | Investor Relations Contact | 2019-05-31 |
| CHITOGENX INC. | Investor Relations Contact | 2019-05-31 |
Québec Bar Assoication
 Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Corporate Officer/Principal | - |
Former positions of Frédéric Dumais
| Companies | Position | End |
|---|---|---|
LAB International, Inc.
 LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Public Communications Contact | 2007-07-12 |
| LIMINAL BIOSCIENCES INC. | Investor Relations Contact | - |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Investor Relations Contact | - |
Akela Pharma, Inc.
 Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Public Communications Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
87
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Health Technology |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Health Technology |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Finance |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
ChitogenX, Inc.
 ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
Valeo Pharma, Inc.
 Valeo Pharma, Inc. Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals & hospital specialty products | Distribution Services |
- Stock Market
- Insiders
- Frédéric Dumais
